Surgical management of deep skull base lesions has historically demanded extensive craniotomies with significant brain retraction. Over the past decade, minimally invasive endoscopic techniques have redefined these surgical paradigms. Specifically, the endoscopic transorbital approach has gained rapid traction as a versatile corridor for addressing ventral and lateral cranial base pathologies. By working through natural orbital planes, surgeons access challenging areas while sparing critical neurovascular structures. Consequently, this technique offers faster postoperative recovery, diminished tissue disruption, and improved cosmetic outcomes. However, defining its precise safety profile and procedural complication rates remains essential for widespread surgical adoption.

Expanding Paradigms: The Endoscopic Transorbital Approach

Surgeons originally designed the endoscopic transorbital approach to access lesions situated within the orbit itself. However, rapid anatomical insights revealed that the orbit provides an excellent natural conduit into the anterior, middle, and even posterior cranial fossae. Through eyelid crease or transconjunctival incisions, clinicians can access the sphenoid wing, cavernous sinus, and Meckel cave without brain retraction. Therefore, this corridor complements the traditional endoscopic endonasal route, which frequently faces lateral anatomical boundaries imposed by the internal carotid artery and cranial nerves.

Moreover, multidisciplinary collaboration between neurosurgeons, oculoplastic surgeons, and otolaryngologists has accelerated this technical evolution. Teams now successfully resect complex extradural and intradural pathologies using this minimally invasive entry point. Consequently, surgical exposure remains direct and coplanar, eliminating the funneling effect seen in deep microsurgical channels. In addition, patients benefit from concealed surgical scars hidden within natural palpebral folds. Despite these obvious advantages, consolidating quantitative safety metrics across global centers remained an unmet necessity until recently.

Methodology of the Landmark Meta-Analysis

To systematically evaluate procedural safety, researchers performed an extensive literature search across PubMed, Embase, Scopus, and Web of Science up to March 2026. The investigators included studies enrolling at least five patients who underwent the transorbital route as the sole surgical modality. Furthermore, eligible trials examined both orbital and skull base pathologies while reporting early and late postoperative complications. The investigators pooled clinical data using a random-effects meta-analysis model with 95% confidence intervals.

Ultimately, eleven observational studies comprising 269 patients met the rigorous inclusion criteria. Across the entire pooled cohort, surgeons treated 21 distinct histopathological entities. Spheno-orbital and cranial base meningiomas represented the vast majority of cases, accounting for 60.6% of all procedures. Schwannomas constituted the second most common pathology at 12.0%, followed by cavernous hemangiomas at 4.6% and gliomas at 2.7%. The mean follow-up duration across the cohort reached 27.6 ± 15.1 months. Thus, this dataset provides a robust foundation for evaluating mid-term and long-term procedural outcomes.

Neurological and Cranial Complications

A primary concern during any skull base intervention is the risk of cerebrospinal fluid (CSF) fistulas and intracranial infections. Fortunately, the meta-analysis established an exceptionally low pooled rate of CSF leaks at only 1% (95% CI: 0.00 to 0.04; I² = 46.5%). Because the transorbital corridor relies on natural anatomical barriers, surgeons can achieve effective multilayer reconstructions when dural defects occur. In addition, the pooled rate of postoperative wound infection was merely 3% (95% CI: 0.01 to 0.07; I² = 0%), demonstrating negligible between-study heterogeneity.

Similarly, the pooled mortality rate across all eleven studies was 0% (95% CI: 0.00 to 0.02; I² = 28.7%). This confirms that the corridor avoids catastrophic neurovascular injury when performed by experienced teams. However, cranial nerve manipulation did produce predictable sensory changes. Transient facial numbness occurred in 16% of patients (95% CI: 0.09 to 0.25; I² = 35.0%), reflecting surgical retraction or dissection along trigeminal nerve branches. Importantly, most sensory disturbances resolved spontaneously during postoperative follow-up, causing minimal long-term functional impairment.

Orbital Outcomes and Visual Function

Because the corridor traverses orbital anatomy, ophthalmic morbidity represents a focal point of clinical evaluation. Postoperative ptosis occurred in 4% of individuals (95% CI: 0.00 to 0.14; I² = 79.4%), whereas persistent or temporary diplopia developed in 6% (95% CI: 0.01 to 0.14; I² = 68.9%). Furthermore, medial gaze palsy was observed in 9% of cases (95% CI: 0.04 to 0.18; I² = 8.8%), secondary to lateral traction on the rectus musculature.

Remarkably, the approach demonstrated outstanding preservation of sight alongside significant therapeutic benefit. Objective improvement in baseline visual function occurred in 47% of patients (95% CI: 0.22 to 0.73; I² = 88.7%). Conversely, new or worsening visual dysfunction developed in only 1% of patients (95% CI: 0.00 to 0.04; I² = 48.6%). Consequently, the data show that timely decompression of the optic canal and orbital apex via this corridor safely restores ocular performance. Therefore, surgical teams can offer this approach with high confidence regarding orbital safety.

Clinical Applications and Future Directions

These findings substantiate the role of transorbital endoscopy as a dependable alternative to extensive open craniotomies for selected lesions. Specifically, patients with spheno-orbital meningiomas causing progressive proptosis and visual loss represent ideal surgical candidates. Furthermore, the corridor serves as a valuable component in multiportal approaches, combining with endonasal corridors to tackle extensive tumors crossing multiple anatomical compartments. This combined multi-angle access maximizes tumor resection while minimizing patient morbidity.

Nevertheless, surgeons must undergo specialized anatomical training and simulation before adopting this technique. Careful patient selection and high-resolution preoperative neuroimaging remain essential prerequisites. In addition, intraoperative neuronavigation and neuromonitoring significantly reduce risks to the optic nerve and orbital contents. Looking ahead, prospective multicentric trials and comparative studies will refine clinical indications further. Ultimately, this approach represents a definitive leap forward in minimally invasive cranial base surgery.

Frequently Asked Questions

What pathologies are best treated with this corridor?

The transorbital corridor is ideal for spheno-orbital meningiomas, middle cranial fossa schwannomas, cavernous hemangiomas, and selected anteromedial temporal lesions. It offers exceptional access to lateral skull base targets that remain difficult to reach safely through standard transnasal or open transcranial routes.

How frequent are cerebrospinal fluid leaks after surgery?

Cerebrospinal fluid leaks occur rarely with this technique. The pooled meta-analysis demonstrated a CSF leak rate of only 1%. Surgeons routinely prevent postoperative leaks by performing meticulous multilayered dural reconstruction using autologous grafts, local vascularized flaps, and bioabsorbable surgical sealants.

Does orbital entry risk permanent ocular motility deficits?

Permanent ocular motility impairment remains uncommon following this procedure. Although transient diplopia occurs in approximately 6% and medial gaze palsy in 9% of cases, most deficits resolve spontaneously within weeks. Overall, nearly half of patients experience significant improvement in preoperative visual function.

Disclaimer: This content is for informational and educational purposes only and should not be considered as professional medical advice. Always consult a healthcare professional for clinical decision-making. Refer to the latest local and national guidelines for clinical practice.

References

Arend RB et al. Safety profile and surgical outcomes of the endoscopic transorbital approach as a skull base surgical corridor: a systematic review and meta-analysis. Neurosurg Rev. 2026 May 13. doi: 10.1007/s10143-026-04321-x. PMID: 42120790.

Vural A, Carobbio ALC, Ferrari M, et al. Transorbital endoscopic approaches to the skull base: a systematic literature review and anatomical description. Neurosurg Rev. 2021;44(5):2857-2874. doi:10.1007/s10143-020-01470-5.

Di Somma A, Guizzardi G, Sanchez España JC, et al. Complications of the Superior Eyelid Endoscopic Transorbital Approach to the Skull Base: Preliminary Experience With Specific Focus on Orbital Outcome. J Neuroophthalmol. 2023;43(4):506-512. doi:10.1097/WNO.0000000000001899.